Results of multivariable analysis using Cox proportional hazards models
| Endpoint . | Covariable . | Hazard ratio . | P . |
|---|---|---|---|
| REM | Imatinib late schedule | 7.156 | <.0001 |
| No CR after IP1 | 4.122 | .01 | |
| CDKN2A/B deletion | 4.066 | .0061 | |
| DFS | Imatinib late schedule | 3.148 | .0004 |
| TBI-based conditioning | 2.915 | .0087 | |
| CDKN2A/B deletion | 2.621 | .0054 | |
| BTG1 deletion | 2.060 | .047 | |
| OS | CDKN2A/B deletion | 2.162 | .014 |
| RIC vs MAC | 1.934 | .069 | |
| Imatinib late schedule | 1.918 | .0429 |
| Endpoint . | Covariable . | Hazard ratio . | P . |
|---|---|---|---|
| REM | Imatinib late schedule | 7.156 | <.0001 |
| No CR after IP1 | 4.122 | .01 | |
| CDKN2A/B deletion | 4.066 | .0061 | |
| DFS | Imatinib late schedule | 3.148 | .0004 |
| TBI-based conditioning | 2.915 | .0087 | |
| CDKN2A/B deletion | 2.621 | .0054 | |
| BTG1 deletion | 2.060 | .047 | |
| OS | CDKN2A/B deletion | 2.162 | .014 |
| RIC vs MAC | 1.934 | .069 | |
| Imatinib late schedule | 1.918 | .0429 |